Accendra Q2 2026: revenue -10% on payor loss; net loss narrows 90% on below-the-line items

Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 11, 2025 · ~1 min read

Key Changes

• high

  Revenue fell 10% to $613.2M, driven by the commercial payor contract termination ($81M Q2 impact, $123M six-month impact). Capitation revenue collapsed 93% to $4.4M in Q2.

  MD&A: Revenue / Notes: Capitation Revenue verify on EDGAR →
• high

  Completed P&HS business sale Dec 2025 for $342M cash (retained 5% equity)

  MD&A: P&HS Sale / Notes: Discontinued Operations verify on EDGAR →
• high

  June 2026 debt restructuring exchanged $1.0B of 4.5%/6.625% unsecured notes for 9.0%/9.75% secured notes due 2032/2033, extending maturities but raising interest costs and subordinating remaining unsecured debt.

  MD&A: Balance Sheet Optimization / Notes: Debt verify on EDGAR →